MTNR1A and congenital rubella syndrome: With respect to the downstream signals of MT1 and MT2, CRS treatment upregulated the phosphorylation level of cyclic adenosine monophosphate (cAMP)-responsive element binding (p-CREB) protein but CREB levels remained unchanged (Figure 7G).